Portal de investigação
The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting.
Autores da FMUP
Participantes de fora da FMUP
- Santos, G
- Fabiano, A
- Mota, PC
- Melo, N
- Alexandre, AT
- Moura, CS
- Guimaraes, S
- Pereira, JM
- Carvalho, A
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG) -NCT05635032
Investigador Principal: Hélder Novais e Bastos
Estudo Observacional Académico (FIBRALUNG) . FCT . 2021
Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Impact of Chronic Obstructive Pulmonary Disease in surgical outcomes of lung cancer patients undergoing curative intent surgery
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Non-invasive assessment of Benign Tracheal Stenosis.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Acromegalia: Metabolismo da Glicose Como Possível Preditor de Tumores Mais Agressivos
Investigador Principal: Davide Maurício Costa Carvalho
Estudo Clínico Académico . 2022
Predictors of lung entrapment in malignant pleural effusion
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2022
Diabetic Neuropathy, Central Nervous System Plasticity and Metabolic Disfunction
Investigador Principal: Davide Maurício Costa Carvalho
Estudo Clínico Académico . 2020
Citar a publicação
Santos G,Fabiano A,Mota PC,Rodrigues I,Carvalho D,Melo N,Novais H,Alexandre AT,Moura CS,Guimaraes S,Pereira JM,Carvalho A,Morais A. The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting. Pulm. Pharmacol. Ther. 2023. 83. p. 102261-102261. IF:3,200. (3).
